Ugasewa Multi Speciality Care Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 1 Year 11 Months
- Last Filing with ROC 31 Mar 2024
About Ugasewa Multi Speciality Care
Ugasewa Multi Speciality Care Private Limited (UMSCPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 March 2023 (One year and 11 months 4 days old ). Its registered office is in Kanyakumari, Tamil Nadu, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nazurudheen Mohammed, Shahul Hidayathunnayeem, Mohamed Badarudeen, and Two other members serve as directors at the Company.
Company Details
-
Location
Kanyakumari, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U86100TN2023PTC158676
-
Company No.
158676
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Mar 2023
-
Date of AGM
23 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Who are the key members and board of directors at Ugasewa Multi Speciality Care?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nazurudheen Mohammed | Managing Director | 04-Mar-2023 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shahul Hidayathunnayeem | Director | 04-Mar-2023 | Current |
Mohamed Badarudeen | Director | 29-May-2023 | Current |
Mohamed Razak | Director | 12-Jun-2023 | Current |
Ameer Kadher | Director | 29-May-2023 | Current |
Financial Performance of Ugasewa Multi Speciality Care.
Enhance accessibility to Ugasewa Multi Speciality Care's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ugasewa Multi Speciality Care?
Unlock access to Ugasewa Multi Speciality Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ugasewa Multi Speciality Care?
Unlock and access historical data on people associated with Ugasewa Multi Speciality Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ugasewa Multi Speciality Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ugasewa Multi Speciality Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.